Cargando…
Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation
Oligonucleotide (ON) drugs, including small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotides, are promising therapeutic agents. However, their low membrane permeability and sensitivity to nucleases present challenges to in vivo delivery. Chemical modifications of the ON offer...
Autores principales: | Sun, Yating, Zhao, Yarong, Zhao, Xiuting, Lee, Robert J., Teng, Lesheng, Zhou, Chenguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158866/ https://www.ncbi.nlm.nih.gov/pubmed/29027965 http://dx.doi.org/10.3390/molecules22101724 |
Ejemplares similares
-
Delivery
of Oligonucleotide Therapeutics: Chemical
Modifications, Lipid Nanoparticles, and Extracellular Vesicles
por: Bost, Jeremy P., et al.
Publicado: (2021) -
A Polyethylenimine-Linoleic Acid Conjugate for Antisense Oligonucleotide Delivery
por: Xie, Jing, et al.
Publicado: (2013) -
Folic acid receptor-targeted human serum albumin nanoparticle formulation of cabazitaxel for tumor therapy
por: Sun, Yating, et al.
Publicado: (2018) -
Small extracellular vesicles encapsulating lefty1 mRNA inhibit hepatic fibrosis
por: Zhao, Yarong, et al.
Publicado: (2022) -
Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies
por: Anwar, Saeed, et al.
Publicado: (2023)